Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.

By J. Aviña-Zubieta, Hyon K. Choi, M. Sadatsafavi, M. Etminan, J. Esdaile, D. Lacaille. Arthritis & Rheumatism, 2008

1,486 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Nephrology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/8ad4456b5ee83653207523d95ee010460d1552b7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. S. Daniels
2. S. Grundy

In Rheumatology

1. I. McInnes
2. I. Graham
3. Massimo F. Piepoli
4. S. Gaffen

Citations in the corpus

• EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis (2009, background): “Obviously, management of patients with inflammatory arthritis focuses not on cardiovascular (CV) morbidity and mortality. However, standardised mortality ratios (SMRs) are raised and the majority of premature deaths are attributable to CV disease.”
• National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. (2015, background): “5- to 2-fold higher in RA compared to individuals from the general population with the same age and gender.(708,709) This elevated CVD risk in RA is attributed to chronic inflammation leading to accelerated atherosclerosis.”